Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2020 07:00 ET | Source: MediWound Ltd.

MediWound Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Submitted Biological License Application to the FDA for NexoBrid EscharEx U.S. Phase 2 Study Resumed Patient Screening YAVNE, Israel, Aug. 06, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd....
July 28, 2020 08:00 ET | Source: MediWound Ltd.

MediWound to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020

YAVNE, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
June 30, 2020 07:00 ET | Source: MediWound Ltd.

MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal Burns

YAVNE, Israel, June 30, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet medical needs in severe...
May 20, 2020 07:00 ET | Source: MediWound Ltd.

MediWound Reports First Quarter 2020 Financial Results and Provides Corporate Update

YAVNE, Israel, May 20, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in...
May 13, 2020 08:00 ET | Source: MediWound Ltd.

MediWound to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 20, 2020

YAVNE, Israel, May 13, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
May 04, 2020 07:30 ET | Source: MediWound Ltd.

MediWound Strengthens its NexoBrid European Presence with Additional Distribution Agreements

YAVNE, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet medical needs in severe...
April 27, 2020 07:00 ET | Source: MediWound Ltd.

MediWound Strengthens Board of Directors

YAVNE, Israel, April 27, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
March 30, 2020 07:30 ET | Source: MediWound Ltd.

MediWound Provides Corporate Update Related to COVID-19 Pandemic

YAVNE, Israel, March 30, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in...
March 03, 2020 06:00 ET | Source: MediWound Ltd.

BARDA Upsizes its Contract with MediWound Awarding an Additional $5.5 Million for Emergency Readiness for NexoBrid Deployment

YAVNE, Israel, March 03, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
February 28, 2020 16:18 ET | Source: MediWound Ltd.

MediWound to Present at Cowen and Company 40th Annual Healthcare Conference

YAVNE, Israel, Feb. 28, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...